INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 48 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,000 | +57.1% | 12,089 | +35.2% | 0.01% | +25.0% |
| Q1 2020 | $7,000 | 0.0% | 8,939 | +24.2% | 0.00% | +33.3% |
| Q4 2019 | $7,000 | +75.0% | 7,200 | +71.4% | 0.00% | +50.0% |
| Q3 2019 | $4,000 | -33.3% | 4,200 | +31.2% | 0.00% | -33.3% |
| Q2 2019 | $6,000 | 0.0% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |